10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,818 | -26.1% | 238 | 0.0% | 0.00% | – |
| Q2 2023 | $13,290 | +0.1% | 238 | 0.0% | 0.00% | – |
| Q1 2023 | $13,278 | +53.1% | 238 | 0.0% | 0.00% | – |
| Q4 2022 | $8,673 | +23.9% | 238 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | -36.4% | 238 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | -38.9% | 238 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | -77.5% | 238 | -55.8% | 0.00% | – |
| Q4 2021 | $80,000 | +1233.3% | 538 | +1315.8% | 0.00% | – |
| Q3 2021 | $6,000 | -14.3% | 38 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -53.3% | 38 | -53.7% | 0.00% | – |
| Q1 2021 | $15,000 | +200.0% | 82 | +115.8% | 0.00% | – |
| Q4 2020 | $5,000 | -99.0% | 38 | -99.0% | 0.00% | -100.0% |
| Q3 2020 | $477,000 | +39.5% | 3,827 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $342,000 | +17000.0% | 3,827 | +9971.1% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 38 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |